These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7861655)

  • 21. Effect of verapamil on cephaloridine nephrotoxicity in the rabbit.
    Browning MC
    Toxicol Appl Pharmacol; 1990 May; 103(3):383-8. PubMed ID: 2339412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between the transport and toxicity of cephalosporins in the kidney.
    Tune BM
    J Infect Dis; 1975 Aug; 132(2):189-94. PubMed ID: 1159324
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of panipenem/betamipron in pediatric field].
    Ido M; Itoh M; Sakurai M; Ihara T; Kamiya H
    Jpn J Antibiot; 1992 Apr; 45(4):398-407. PubMed ID: 1518122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetic analysis of panipenem/betamipron in patients with various degrees of renal function.
    Tajima N; Ishizuka H; Naganuma H
    Chemotherapy; 2006; 52(5):245-53. PubMed ID: 16864999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal handling of CS-023 (RO4908463), a novel parenteral carbapenem antibiotic, in rabbits in comparison with meropenem.
    Shibayama T; Yamamura N; Matsushita Y; Tokui T; Hirota T; Ikeda T
    Xenobiotica; 2006 Dec; 36(12):1273-87. PubMed ID: 17162472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of piperonyl butoxide on cephalosporin nephrotoxicity in the rabbit. An effect on cephaloridine transport.
    Tune BM; Kuo CH; Hook JB; Hsu CY; Fravert D
    J Pharmacol Exp Ther; 1983 Mar; 224(3):520-4. PubMed ID: 6827476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural features of carbapenem compounds for nephrotoxicity: effect of C-2 side chain.
    Nouda H; Matsumura H; Tanio T; Sunagawa M
    J Antibiot (Tokyo); 1996 Jun; 49(6):603-6. PubMed ID: 8698647
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacokinetics and clinical studies of panipenem/betamipron in the pediatric field].
    Fujisawa Y; Tauchi H; Kida K; Matsuda H
    Jpn J Antibiot; 1992 Apr; 45(4):443-51. PubMed ID: 1518128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rabbit renal proximal tubule suspensions as a model for nephrotoxicity evaluation of native or in situ metabolized beta-lactam antibiotics.
    Dutertre-Catella H; Martin C; Debray M; Pham-Huy C; Thevenin M; Warnet JM; Podevin RA; Claude JR
    Arch Toxicol Suppl; 1995; 17():215-7. PubMed ID: 7786159
    [No Abstract]   [Full Text] [Related]  

  • 30. Interaction of aminoglycosides and cephaloridine in the rabbit kidney.
    Dolislager D; Fravert D; Tune BM
    Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):13-23. PubMed ID: 515499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal dehydropeptidase-I stability of LJC 10,627, a new carbapenem antibiotic.
    Hikida M; Kawashima K; Nishiki K; Furukawa Y; Nishizawa K; Saito I; Kuwao S
    Antimicrob Agents Chemother; 1992 Feb; 36(2):481-3. PubMed ID: 1605616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nephrotoxicity of beta-lactam antibiotics: mechanisms and strategies for prevention.
    Tune BM
    Pediatr Nephrol; 1997 Dec; 11(6):768-72. PubMed ID: 9438663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age-dependent renal accumulation of cephaloridine in the rabbit.
    Wold JS; Turnipseed SA
    Drug Metab Dispos; 1978; 6(1):87-90. PubMed ID: 23280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting renal OATs to develop renal protective agent from traditional Chinese medicines: Protective effect of Apigenin against Imipenem-induced nephrotoxicity.
    Huo X; Meng Q; Wang C; Wu J; Zhu Y; Sun P; Ma X; Sun H; Liu K
    Phytother Res; 2020 Nov; 34(11):2998-3010. PubMed ID: 32468621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics of the carbapenems: clinical implications.
    Mouton JW; Touzw DJ; Horrevorts AM; Vinks AA
    Clin Pharmacokinet; 2000 Sep; 39(3):185-201. PubMed ID: 11020134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of cephalosporin nephrotoxicity by other cephalosporins and by penicillins without significant inhibition of renal cortical uptake.
    Tune BM; Browning MC; Hsu CY; Fravert D
    J Infect Dis; 1982 Feb; 145(2):174-80. PubMed ID: 7054322
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical concentration of 'unbound' cadmium in the rabbit renal cortex.
    Nomiyama K; Nomiyama H
    Experientia; 1986 Feb; 42(2):149. PubMed ID: 3948969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of cephalosporins on organic ion transport in renal membrane vesicles from rat and rabbit kidney cortex.
    Williams PD; Hitchcock MJ; Hottendorf GH
    Res Commun Chem Pathol Pharmacol; 1985 Mar; 47(3):357-71. PubMed ID: 2986254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
    Rababa’h AM; Hijjawi TB; Alzoubi KH; Al Demour S; Ababneh MA
    Curr Mol Pharmacol; 2018; 11(2):155-161. PubMed ID: 28762308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.